Galena Biopharma, Inc. (NASDAQ:GALE)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar cmrk3 (40.85) Submitted: 7/9/2012 3:18:54 PM : Outperform Start Price: $1.72 GALE Score: +3.26

http://www.rttnews.com/1909609/what-hails-galena-biopharma.aspx The test results for their breast cancer drug and booster is looking very good.

Report this Post Reply

Featured Broker Partners


Advertisement